Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for HCW Biologics (HCWB) over the last 6 years, with Q3 2025 value amounting to -$1.3 million.

  • HCW Biologics' Net Cash Flow fell 72287.59% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98688.0, marking a year-over-year increase of 10096.54%. This contributed to the annual value of $1.1 million for FY2024, which is 10576.29% up from last year.
  • HCW Biologics' Net Cash Flow amounted to -$1.3 million in Q3 2025, which was down 72287.59% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, HCW Biologics' Net Cash Flow registered a high of $95.1 million during Q4 2021, and its lowest value of -$88.5 million during Q3 2021.
  • Its 5-year average for Net Cash Flow is -$387311.8, with a median of -$1.6 million in 2021.
  • Over the last 5 years, HCW Biologics' Net Cash Flow had its largest YoY gain of 472165.68% in 2021, and its largest YoY loss of 276874.86% in 2021.
  • Quarter analysis of 5 years shows HCW Biologics' Net Cash Flow stood at $95.1 million in 2021, then plummeted by 104.1% to -$3.9 million in 2022, then tumbled by 95.64% to -$7.6 million in 2023, then skyrocketed by 148.21% to $3.7 million in 2024, then crashed by 136.51% to -$1.3 million in 2025.
  • Its last three reported values are -$1.3 million in Q3 2025, $1.3 million for Q2 2025, and -$3.6 million during Q1 2025.